UNITED THERAPEUTICS Corp
UTHR
146 insider filings · Latest: Jun 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 1 8:57 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $572.63 | $5.4M | 40,513(D) | View → |
| Apr 30, 2026 | May 1 8:56 PM | James EdgemondCFO AND TREASURER | Sale | 10,000 | $572.61 | $5.7M | 18,876(D) | View → |
| May 1, 2026 | May 1 8:46 PM | MARTINE ROTHBLATT | Proposed Sale | 190,000 | $571.35 | $108.6M | — | View → |
| Apr 29, 2026 | Apr 30 8:30 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $571.22 | $5.4M | 40,513(D) | View → |
| Apr 28, 2026 | Apr 29 8:31 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $568.04 | $5.4M | 40,513(D) | View → |
| Apr 27, 2026 | Apr 28 10:04 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $568.81 | $5.4M | 40,513(D) | View → |
| Apr 27, 2026 | Apr 28 9:30 PM | James EdgemondCFO AND TREASURER | Sale | 10,000 | $568.83 | $5.7M | 18,876(D) | View → |
| Apr 24, 2026 | Apr 27 8:39 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $564.81 | $5.4M | 40,513(D) | View → |
| Apr 23, 2026 | Apr 24 8:32 PM | James EdgemondCFO AND TREASURER | Sale | 9,636 | $572.21 | $5.5M | 18,876(D) | View → |
| Apr 22, 2026 | Apr 24 8:32 PM | James EdgemondCFO AND TREASURER | Sale | 364 | $575.85 | $209.6K | 18,996(D) | View → |
| Apr 23, 2026 | Apr 24 8:32 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $572.35 | $5.4M | 40,513(D) | View → |
| Apr 24, 2026 | Apr 24 8:31 PM | Christopher PatuskyDirector | Sale | 2,910 | $569.00 | $1.7M | 1,490(D) | View → |
| Apr 24, 2026 | Apr 24 8:01 PM | CHRISTOPHER PATUSKY | Proposed Sale | 2,910 | $569.00 | $1.7M | — | View → |
| Apr 22, 2026 | Apr 23 8:53 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $576.56 | $5.5M | 40,513(D) | View → |
| Apr 21, 2026 | Apr 22 8:30 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $570.42 | $5.4M | 40,513(D) | View → |
| Apr 20, 2026 | Apr 21 11:41 AM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $577.83 | $5.5M | 40,513(D) | View → |
| Apr 20, 2026 | Apr 21 11:41 AM | James EdgemondCFO AND TREASURER | Sale | 10,000 | $577.86 | $5.8M | 18,876(D) | View → |
| Apr 17, 2026 | Apr 20 8:38 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $586.66 | $5.6M | 40,513(D) | View → |
| Apr 17, 2026 | Apr 17 8:57 PM | Christopher PatuskyDirector | Sale | 1,000 | $578.88 | $578.9K | 1,490(D) | View → |
| Apr 16, 2026 | Apr 17 8:57 PM | Martine A RothblattDirector, Chairperson & CEO | Sale | 9,500 | $577.21 | $5.5M | 40,513(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 5 9:35 PM | Tommy G ThompsonDirector | Option Exercise | 2,000 | $101.80 | 2,000(D) | View → |
| Mar 4, 2026 | Mar 5 9:34 PM | Christopher CauseyDirector | Option Exercise | 20 | $119.76 | 6,300(D) | View → |
| Mar 3, 2026 | Mar 5 9:33 PM | Martine A RothblattDirector, Chairperson & CEO | Option Exercise | 9,500 | $146.03 | 221,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:31 PM | Martine A RothblattDirector, Chairperson & CEO | Option Exercise | 9,500 | $146.03 | 230,500(D) | View → |
| Mar 15, 2023 | Feb 26 9:31 PM | Paul A MahonEVP & GENERAL COUNSEL | Grant/Award | 66,551 | $217.50 | 8,895(D) | View → |
| Mar 15, 2023 | Feb 26 9:31 PM | Martine A RothblattDirector, Chairperson & CEO | Grant/Award | 277,299 | $217.50 | 37,080(D) | View → |
| Mar 15, 2023 | Feb 26 9:30 PM | Michael BenkowitzPRESIDENT AND COO | Grant/Award | 133,102 | $217.50 | 17,790(D) | View → |
| Mar 15, 2023 | Feb 26 9:30 PM | James EdgemondCFO AND TREASURER | Grant/Award | 77,648 | $217.50 | 10,380(D) | View → |
| Feb 25, 2026 | Feb 25 9:31 PM | Christopher CauseyDirector | Option Exercise | 1,000 | $119.76 | 6,320(D) | View → |
| Feb 23, 2026 | Feb 24 9:31 PM | Michael BenkowitzPRESIDENT AND COO | Option Exercise | 14,440 | $146.03 | 0(I) | View → |
| Feb 19, 2026 | Feb 19 9:31 PM | Paul A MahonEVP & GENERAL COUNSEL | Option Exercise | 8,300 | $146.03 | 41,800(D) | View → |
| Feb 17, 2026 | Feb 18 9:31 PM | Michael BenkowitzPRESIDENT AND COO | Option Exercise | 22,500 | $146.03 | 5,065(I) | View → |
| Feb 9, 2026 | Feb 10 9:30 PM | Michael BenkowitzPRESIDENT AND COO | Option Exercise | 22,500 | $146.03 | 12,940(I) | View → |
| Feb 5, 2026 | Feb 5 9:31 PM | Paul A MahonEVP & GENERAL COUNSEL | Option Exercise | 8,300 | $146.03 | 50,100(D) | View → |
| Feb 2, 2026 | Feb 3 9:31 PM | Michael BenkowitzPRESIDENT AND COO | Option Exercise | 22,500 | $146.03 | 20,815(I) | View → |
| Jan 26, 2026 | Jan 28 9:31 PM | Michael BenkowitzPRESIDENT AND COO | Option Exercise | 22,500 | $146.03 | 28,690(I) | View → |
| Jan 20, 2026 | Jan 28 9:31 PM | Michael BenkowitzPRESIDENT AND COO | Option Exercise | 7,875 | $146.03 | 36,565(I) | View → |
| Jan 20, 2026 | Jan 28 9:30 PM | Michael BenkowitzPRESIDENT AND COO | Option Exercise | 14,625 | $146.03 | 67,875(I) | View → |
| Jan 21, 2026 | Jan 23 9:32 PM | Kevin TraceyDirector | Grant/Award | 1,220 | — | 1,220(D) | View → |
← Previous
Page 7 of 7